A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home) (Asia BP@Home)
Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.
Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.
研究概览
详细说明
Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.
The main purpose of this study is to:
- Assess HBP control status in each Asian country
- Develop an Asian consensus and Asia-specific treatment for hypertension
- Improve the management of hypertension in Asia by encouraging patients to monitor HBP
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Tochigi、日本
- Jichi Medical University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Inclusion criteria:
- Age >= 20 years
- Subjects with stable medication (> 3 months) diagnosed as hypertension
- Asian
- Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.
描述
Inclusion Criteria:
- Age >= 20 years
- Subjects with stable medication (> 3 months) diagnosed as hypertension
- Asian
- Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.
Exclusion Criteria:
-
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Distribution rate based on the home BP of the patients.
大体时间:7 days or more blood pressure measurement
|
Distribution rate based on the home BP of the patients who are defined as:
|
7 days or more blood pressure measurement
|
合作者和调查者
调查人员
- 首席研究员:Kazuomi Kario, MD, PhD、Jichi Medical University School of Medicine
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.